1. Home
  2. VEEA vs ELTX Comparison

VEEA vs ELTX Comparison

Compare VEEA & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEA
  • ELTX
  • Stock Information
  • Founded
  • VEEA 2014
  • ELTX 2011
  • Country
  • VEEA United States
  • ELTX United States
  • Employees
  • VEEA N/A
  • ELTX N/A
  • Industry
  • VEEA
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VEEA
  • ELTX Health Care
  • Exchange
  • VEEA NYSE
  • ELTX Nasdaq
  • Market Cap
  • VEEA 112.2M
  • ELTX 121.7M
  • IPO Year
  • VEEA N/A
  • ELTX N/A
  • Fundamental
  • Price
  • VEEA $1.60
  • ELTX $5.40
  • Analyst Decision
  • VEEA
  • ELTX Strong Buy
  • Analyst Count
  • VEEA 0
  • ELTX 2
  • Target Price
  • VEEA N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • VEEA 15.3K
  • ELTX 35.5K
  • Earning Date
  • VEEA 05-23-2025
  • ELTX 05-19-2025
  • Dividend Yield
  • VEEA N/A
  • ELTX N/A
  • EPS Growth
  • VEEA N/A
  • ELTX N/A
  • EPS
  • VEEA N/A
  • ELTX N/A
  • Revenue
  • VEEA $141,760.00
  • ELTX N/A
  • Revenue This Year
  • VEEA N/A
  • ELTX N/A
  • Revenue Next Year
  • VEEA N/A
  • ELTX N/A
  • P/E Ratio
  • VEEA N/A
  • ELTX N/A
  • Revenue Growth
  • VEEA N/A
  • ELTX N/A
  • 52 Week Low
  • VEEA $1.33
  • ELTX $3.34
  • 52 Week High
  • VEEA $18.56
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • VEEA N/A
  • ELTX 48.43
  • Support Level
  • VEEA N/A
  • ELTX $4.85
  • Resistance Level
  • VEEA N/A
  • ELTX $5.94
  • Average True Range (ATR)
  • VEEA 0.00
  • ELTX 0.50
  • MACD
  • VEEA 0.00
  • ELTX 0.14
  • Stochastic Oscillator
  • VEEA 0.00
  • ELTX 56.45

About VEEA VEEA INC

Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: